Get an essential, high-impact briefing on the breakthrough science and practice-changing guidelines unveiled at the 2025 ADA and EASD meetings. This course cuts through the noise to deliver the specific data that will immediately redefine your patient management strategies. We will analyze major clinical trial results impacting cardio-renal-metabolic outcomes, review updates to the consensus statements on T2D pharmacotherapy, and showcase the newest technologies that are transforming glucose monitoring and insulin delivery. This is your rapid-fire guide to translating global research into superior patient care starting tomorrow.